as on February 5, 2026 at 2:29 am IST
Day's Low
Day's High
1.69%
Downside
4.07%
Upside
52 Week's Low
52 Week's High
53.93%
Downside
37.94%
Upside
Check Verrica Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$118.2M
EPS (TTM)
-0.425
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.2
Industry PE ratio
-2.821844380403458
PEG Ratio
0EBITDA
-15.0M
Revenue (TTM)
30.8M
Profit Margin
-84.38%
Return On Equity TTM
-1546.58%
Track how Verrica Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Verrica Pharmaceuticals Inc in the last 5 years
Lowest (-121.44x)
June 30, 2023
Industry (-2.82x)
February 5, 2026
Today (-1.20x)
February 5, 2026
Highest (-5.57x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.20x
Compare market cap, revenue, PE, and other key metrics of Verrica Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $118.2M | -94.89% | -1.2 | -84.38% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
The Verrica Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Verrica Pharmaceuticals Inc investment value today
Current value as on today
₹1,06,615
Returns
₹6,615
(+6.62%)
Returns from Verrica Pharmaceuticals Inc Stock
₹2,742 (+2.74%)
Dollar Returns*
₹3,873 (+3.87%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Verrica Pharmaceuticals Inc. Average target price of $16.5
Get share price movements and forecasts by analysts on Verrica Pharmaceuticals Inc.
What analysts predicted
56.85%UPSIDE
Target Price
$16.5
Current Price
$7.12
Analyzed by
12 Analysts
Target
$16.50
Verrica Pharmaceuticals Inc target price $16.5, a slight upside of 56.85% compared to current price of $7.12. According to 12 analysts rating.
Search interest for Verrica Pharmaceuticals Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, VRCA stock has moved up by 107.0%
Revenue Rich
![]()
Revenue is up for the last 5 quarters, -1.78M → 14.34M (in $), with an average increase of 198.0% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.6% return, outperforming this stock by 51.5%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 37.0% return, outperforming this stock by 123.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 204.0K → -274.0K (in $), with an average decrease of 234.3% per quarter
| Organisation | Verrica Pharmaceuticals Inc |
| Headquarters | 44 West Gay Street, West Chester, PA, United States, 19380 |
| Industry | Health Technology |
| CEO | Dr. Jayson M. Rieger M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jayson M. Rieger M.B.A., Ph.D. | President, CEO & Director |
Mr. John J. Kirby CPA | Interim Chief Financial Officer |
Mr. David Zawitz | Chief Operating Officer |
Mr. Eugene Scavola | Executive Vice President of Technical Operations |
Dr. Bradley J. Catalone MBA, Ph.D. | Head of Drug Development |
Dr. Noah L. Rosenberg M.D. | Chief Medical Officer |
Verrica Pharmaceuticals Inc share price today is $7.12 as on at the close of the market. Verrica Pharmaceuticals Inc share today touched a day high of $7.41 and a low of $7.
Verrica Pharmaceuticals Inc share touched a 52 week high of $9.82 on and a 52 week low of $3.28 on . Verrica Pharmaceuticals Inc stock price today i.e. is closed at $7.12,which is 27.50% down from its 52 week high and 117.07% up from its 52 week low.
Verrica Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Verrica Pharmaceuticals Inc (VRCA) shares with as little as ₹90.453 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Verrica Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Verrica Pharmaceuticals Inc share’s latest price of $7.12 as on February 5, 2026 at 2:29 am IST, you will get 1.4045 shares of Verrica Pharmaceuticals Inc. Learn more about
fractional shares .
Verrica Pharmaceuticals Inc stock has given -94.89% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?